Market Overview

Biosimilars Research Report 2018: Patent Cliffs and Regulatory Changes Driving the Growth, Competitive Scenario and Market Dynamics -


The "Biosimilars:
Patent Cliffs and Regulatory Changes Driving the Growth, Competitive
Scenario and Market Dynamics"
report has been added to's

Biosimilars are in the limelight with various leaders in the
biopharmaceutical industry eyeing these biosimilars, be it biologic
innovators, generic manufacturers or contract channel partners.

The emergence of biosimilar medicines across Europe and in the United
States brings the promise of new valuable sources. The forecast of more
affordable options that are safe and effective opens opportunities for
health systems to broaden accessibility to biologics for more patients,
make resources available for investment in new domains, and bring down
healthcare budgets.

With better defined regulatory pathways and expiries, Biosimilars Market
will be boosted and will return a stupendous CAGR of more than 55% over
the forecast period.

This report highlights the benefits and opportunities of Biosimilars in
the biopharmaceutical industry, in comparison to biologics and bio

The report also mentions the development strategy of Biosimilars, the
regulatory framework, and approvals required for development as well as
the strategies to globally commercialize biosimilars for healthcare

The information regarding biosimilars pipeline available as of now along
with the upcoming clinical trials of other drugs, expiration status of
major biosimilars and the emerging players to look out for is also
available in this report.

Market Overview of Biosimilars market has been highlighted w.r.t. to
various factors that determine the market, market segmentation by
region, product, disease indication, etc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Biosimilars- Overview

4. Commercial & Technical Analysis-Biosimilars

5. Biosimilars: Market Overview

6. Biosimilars - Market Determinants

7. Biosimilars - Opportunity Vs. Restraints

8. Biosimilars Strategic Analysis SWOT & PEST

9. List of Tables

10. List of Figures

11. Appendix

For more information about this report visit

View Comments and Join the Discussion!